Published in Biochem Biophys Res Commun on October 22, 2004
Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta (2009) 1.33
Transglutaminases and neurodegeneration. J Neurochem (2009) 1.03
Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin. Br J Pharmacol (2011) 0.95
Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose. J Biomed Biotechnol (2009) 0.86
Characterization of transglutaminase type II role in dendritic cell differentiation and function. J Leukoc Biol (2010) 0.84
Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2. Inflamm Res (2009) 0.83
Transglutaminase activation in neurodegenerative diseases. Future Neurol (2009) 0.79
Significant association of estrogen receptor binding site variation with bipolar disorder in females. PLoS One (2012) 0.79
A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor. Korean J Ophthalmol (2010) 0.77
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes? Amino Acids (2016) 0.75
Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter. PLoS One (2014) 0.75
Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol (2003) 2.08
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med (2006) 1.94
Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res (2010) 1.86
Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci (2005) 1.44
Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A (2003) 1.40
Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res (2006) 1.36
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem (2008) 1.35
Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J Biol Chem (2004) 1.32
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res (2003) 1.32
The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal (2009) 1.31
Polyneuropathy and cerebral infarction complicating scrub typhus. J Clin Neurol (2008) 1.28
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J (2006) 1.22
Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res (2003) 1.13
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer. J Cancer Res Clin Oncol (2009) 1.13
Acrolein inhalation prevents vascular endothelial growth factor-induced mobilization of Flk-1+/Sca-1+ cells in mice. Arterioscler Thromb Vasc Biol (2011) 1.13
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis. PLoS Genet (2011) 1.12
NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid Redox Signal (2012) 1.12
Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest (2003) 1.08
Spontaneously developed pulmonary arterial intramural hematoma that mimicked thromboembolism. Korean J Radiol (2012) 1.07
A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiol Dis (2004) 1.06
Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm Allergy Drug Targets (2009) 1.05
Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3. Neurotox Res (2009) 1.04
Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Brain Res Mol Brain Res (2003) 1.03
Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol (2011) 1.03
Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology (2011) 1.03
Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics (2008) 1.02
Acute fatal stroke immediately following autologous fat injection into the face. Neurology (2003) 1.02
Generation of high-contrast, 30 fs, 1.5 PW laser pulses from chirped-pulse amplification Ti:sapphire laser. Opt Express (2012) 1.01
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J Neuropathol Exp Neurol (2005) 1.00
Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res (2002) 1.00
Pathological dynamics of activated microglia following medial forebrain bundle transection. Glia (2006) 1.00
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma. FASEB J (2013) 0.99
Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate. Int J Biol Macromol (2010) 0.98
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A (2011) 0.98
Exposure to ambient air fine particulate matter prevents VEGF-induced mobilization of endothelial progenitor cells from the bone marrow. Environ Health Perspect (2012) 0.98
Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry (2005) 0.98
Enhancement of electron energy to the multi-GeV regime by a dual-stage laser-wakefield accelerator pumped by petawatt laser pulses. Phys Rev Lett (2013) 0.97
Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death. J Biol Chem (2011) 0.97
Spectrally-sampled OCT for sensitivity improvement from limited optical power. Opt Express (2008) 0.96
Auditory neural pathway evaluation on sensorineural hearing loss using diffusion tensor imaging. Neuroreport (2004) 0.96
Combined categorical reporting systems of US and cytology findings for thyroid nodules: guidance on repeat fine-needle aspiration cytology. Radiology (2012) 0.95
Effect of task-specific training on functional recovery and corticospinal tract plasticity after stroke. Restor Neurol Neurosci (2013) 0.94
Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J Biol Chem (2010) 0.94
NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease. J Neurosci (2012) 0.93
Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation. Biochem Biophys Res Commun (2010) 0.92
The differences in neural network activity between methamphetamine abusers and healthy subjects performing an emotion-matching task: functional MRI study. NMR Biomed (2011) 0.92
Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. J Immunol (2011) 0.92
Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway. Neuropharmacology (2012) 0.92
Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Protein Expr Purif (2010) 0.92
The cervical range of motion as a factor affecting outcome in patients with congenital muscular torticollis. Ann Rehabil Med (2013) 0.92
Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy. J Neuropathol Exp Neurol (2003) 0.92
MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease. Mediators Inflamm (2013) 0.91
Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography. J Korean Med Sci (2009) 0.91
Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition. Cancer Lett (2008) 0.91
Cefepime neurotoxicity in patients with renal insufficiency. Ann Rehabil Med (2012) 0.91
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease. Neurotherapeutics (2013) 0.90
Tissue transglutaminase antibodies in individuals with celiac disease bind to thyroid follicles and extracellular matrix and may contribute to thyroid dysfunction. Thyroid (2008) 0.90
Large temperature sensitivity of Sagnac loop interferometer based on the birefringent holey fiber filled with metal indium. Opt Express (2009) 0.89
Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke (2011) 0.89
Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Biomol Ther (Seoul) (2012) 0.89
Imaging findings of intravascular papillary endothelial hyperplasia presenting in extremities: correlation with pathological findings. Skeletal Radiol (2010) 0.89
Neural correlates related to action observation in expert archers. Behav Brain Res (2011) 0.88
Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection. J Pineal Res (2010) 0.87
Increased tissue transglutaminase expression in human atherosclerotic coronary arteries. Coron Artery Dis (2008) 0.87
Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Lett (2008) 0.87
Flavonoids inhibit the AU-rich element binding of HuC. BMB Rep (2009) 0.87
Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression. Exp Neurol (2007) 0.86
0.1 Hz 1.0 PW Ti:sapphire laser. Opt Lett (2010) 0.86
Effect of 710 nm visible light irradiation on neurite outgrowth in primary rat cortical neurons following ischemic insult. Biochem Biophys Res Commun (2012) 0.86
Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem Res (2005) 0.86
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models. J Cancer Res Clin Oncol (2014) 0.86
Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140. Proc Natl Acad Sci U S A (2013) 0.85
Transition of proton energy scaling using an ultrathin target irradiated by linearly polarized femtosecond laser pulses. Phys Rev Lett (2013) 0.85
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer. Mol Cancer (2011) 0.85
A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia. Neuropharmacology (2004) 0.84
Mutants in the Candida glabrata glycerol channels are sensitized to cell wall stress. Eukaryot Cell (2012) 0.84
Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg Med Chem Lett (2010) 0.84
A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice. Exp Lung Res (2006) 0.84
Inhibition of gene expression and production of iNOS and TNF-alpha in LPS-stimulated microglia by methanol extract of Phellodendri cortex. Int Immunopharmacol (2007) 0.84
Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues. Front Biosci (Landmark Ed) (2009) 0.84
Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1. Neurochem Int (2010) 0.83
NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia. Antioxid Redox Signal (2014) 0.83
Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes. Neurochem Res (2008) 0.83
Usefulness of the Scale for the Assessment and Rating of Ataxia (SARA) in Ataxic Stroke Patients. Ann Rehabil Med (2011) 0.83
Amplitude and phase reconstruction of electron wave packets for probing ultrafast photoionization dynamics. Phys Rev Lett (2012) 0.83
Tnfaip8 l1/Oxi-β binds to FBXW5, increasing autophagy through activation of TSC2 in a Parkinson's disease model. J Neurochem (2014) 0.83
Microglial phagocytosis of dopamine neurons at early phases of apoptosis. Cell Mol Neurobiol (2003) 0.82
Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition. Biochem Pharmacol (2013) 0.82
Manganese-enhanced auditory tract-tracing MRI with cochlear injection. Magn Reson Imaging (2006) 0.82
Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor. J Korean Med Sci (2013) 0.82
Magnetic resonance findings of acute severe lower back pain. Ann Rehabil Med (2012) 0.82
Amyloid precursor protein gene disruption attenuates degeneration of substantia nigra compacta neurons following axotomy. Brain Res (2002) 0.82
Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster. J Biol Chem (2006) 0.82